JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 33 No. 9 1654-1660
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jönsson, B.-A.
Right arrow Articles by Andersson, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jönsson, B.-A.
Right arrow Articles by Andersson, L.

Radiation Dosimetry for Indium-111-Labeled Anti-CEA-F(ab')2 Fragments Evaluated from Tissue Distribution in Rats

Bo-Anders Jönsson, Sven-Erik Strand and Lena Andersson

Department of Radiation Physics, University of Lund, Sweden

Correspondence: For reprints contact: Bo-Anders Jönsson, PhD, Department of Radiation Physics, University of Lund, Lasarettet, S-221 85 Lund, Sweden.

ABSTRACT

Accurate dosimetric investigations are important to be able to fulfill the ambition of radiation protection in nuclear medicine and to minimize the radiation burden to the patient. This paper presents human radiation absorbed dose estimates following an administration of an 111In-labeled anti-CEA-F(ab')2 (BW431/31) based on detailed biodistribution and elimination data in a rat model. Animals were followed from the time of injection up to 28 days after injection. A significant initial uptake of 111In in the bone marrow, 25% of injected activity, was evident after 6 hr. The kidneys showed a maximal uptake of 20% at 24 hr. At the end of the study, 27% of the activity was still retained in the whole body. The estimated humans absorbed dose to the kidneys, testes, spleen and bone marrow was 2.27, 0.80, 0.51 and 0.37 mGy MBq–1, respectively. The effective dose was estimated to 0.27 mSv MBq–1. The tissue distribution in rats was comparable to that in humans, which was confirmed by whole-body scintigrams and human biopsies.




This article has been cited by other articles:


Home page
JNMHome page
J. S. Nettleton, R. S. Lawson, M. C. Prescott, and I. D. Morris
Uptake, Localization, and Dosimetry of 111In and 201Tl in Human Testes
J. Nucl. Med., January 1, 2004; 45(1): 138 - 146.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1992 by the Society of Nuclear Medicine.